Bile Duct Cancer, Also Known As Cholangiocarcinoma, Is A Rare Malignancy Of The Bile Ducts. It Primarily Affects The Biliary Tree, Which Is A Network Of Tubes That Carry Bile From The Liver To The Small Intestine. Biliary Tree Cancer Can Be Divided Into Two Main Types: Intrahepatic Cholangiocarcinoma Which Affects The Bile Ducts Within The Liver And Extrahepatic Cholangiocarcinoma Which Affects The Bile Ducts Outside The Liver. The Exact Cause Of Bile Duct Cancer Is Not Known. However, It Has Been Linked To Certain Risk Factors, Such As A History Of Liver Disease, Chronic Infection Of The Bile Ducts, Or A Genetic Predisposition. It Is Also Associated With Certain Environmental Factors, Including Long-Term Exposure To Certain Industrial Chemicals And Certain Types Of Radiation. Bile Duct Cancer Is Usually Diagnosed With Imaging Tests, Such As Ultrasound, CT Scan, Or MRI. Depending On The Type And Stage Of The Cancer, Treatment May Involve Surgery, Radiation, Chemotherapy, Or Targeted Therapy. Surgery Is Usually The First Line Of Treatment For Bile Duct Cancer. Depending On The Size And Location Of The Tumor, It May Involve Removing The Entire Biliary Tree Or Just The Affected Section. In Some Cases, The Surgeon May Need To Remove Part Of The Liver. Radiation Therapy Is Another Option To Treat Bile Duct Cancer. It May Be Used To Shrink The Tumor Before Surgery Or After Surgery To Destroy Any Remaining Cancer Cells. Chemotherapy May Also Be Used To Treat Bile Duct Cancer. It Involves Using Drugs To Kill Cancer Cells. Targeted Therapy Is A Type Of Treatment That Uses Drugs That Specifically Target Cancer Cells, Leaving Healthy Cells Unharmed. This Type Of Therapy Has Recently Been Used To Treat Bile Duct Cancer And May Be Used In Combination With Surgery, Radiation, And/Or Chemotherapy. The Prognosis For Bile Duct Cancer Is Generally Poor, As It Is Often Diagnosed In Advanced Stages. However, Early Diagnosis And Treatment May Increase The Chances Of A Successful Outcome.
Title : Early and late evaluation of esophageal mucosectomy in surgical treatment of advanced esophageal achalasia
Jose Luis Braga De Aquino, Pontifical Catholic University of Campinas, Brazil
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Invention City, United States
Title : Nanoemulsions as a strategy to enhance gastrointestinal bioavailability and bioactivity of lipid based nutraceuticals
Pubali Dhar, University of Calcutta, India
Title : Professional dining and health
Yaffa Machnes, Bar-Ilan University, Israel
Title : Sickle cell liver disease: A multidisciplinary hemato-hepatology approach
Bandar Aljudaibi, King Faisal Specialists Hospital and Research Centre, Saudi Arabia
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, Department of Public Health of Romagna, Italy